EPO Patent Publication EP4493556A1: NLRP3 Modulators
Summary
The European Patent Office (EPO) published patent application EP4493556A1 on March 18, 2026, related to NLRP3 modulators. The patent application lists Zomagen Biosciences Ltd as the applicant.
What changed
The European Patent Office (EPO) has published patent application EP4493556A1, concerning NLRP3 modulators. The publication date is March 18, 2026, and the applicant is Zomagen Biosciences Ltd. This publication details potential new therapeutic agents and their applications, as indicated by the extensive IPC classifications covering various medical conditions.
This patent publication is primarily an informational notice for the pharmaceutical and biotechnology sectors. It does not impose immediate compliance obligations but serves as a notification of intellectual property filings. Companies operating in drug development, particularly those researching inflammatory or metabolic diseases, should note this filing as it may impact future competitive landscapes or licensing opportunities.
Source document (simplified)
NLRP3 MODULATORS
Publication EP4493556A1 Kind: A1 Mar 18, 2026
Applicants
Zomagen Biosciences Ltd
Inventors
COLLINS, James, BOLLU, Venkat, YUAN, Shendong, NUSS, John
IPC Classifications
C07D 403/06 20060101AFI20240917BHEP A61K 31/501 20060101ALI20240917BHEP A61K 31/502 20060101ALI20240917BHEP A61K 31/55 20060101ALI20240917BHEP A61P 1/04 20060101ALI20240917BHEP A61P 1/16 20060101ALI20240917BHEP A61P 3/00 20060101ALI20240917BHEP A61P 3/04 20060101ALI20240917BHEP A61P 3/10 20060101ALI20240917BHEP A61P 9/00 20060101ALI20240917BHEP A61P 9/10 20060101ALI20240917BHEP A61P 11/00 20060101ALI20240917BHEP A61P 11/06 20060101ALI20240917BHEP A61P 17/06 20060101ALI20240917BHEP A61P 19/06 20060101ALI20240917BHEP A61P 25/08 20060101ALI20240917BHEP A61P 25/16 20060101ALI20240917BHEP A61P 25/24 20060101ALI20240917BHEP A61P 25/28 20060101ALI20240917BHEP A61P 37/00 20060101ALI20240917BHEP C07D 413/06 20060101ALI20240917BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.